FibroScan Discordance With Liver Biopsy Significantly Overestimates Advanced Fibrosis and Cirrhosis in MASLD Subjects With Class 3 Obesity: Implications for Resmetirom Eligibility

• Published in: Journal of clinical gastroenterology
• Main Authors: Velji-Ibrahim, Jena, Woodard, Jordan, Alden, Jay, Abrams, Gary A
• Format: Journal Article
• Language: English
• Published: United States 10.01.2025

To investigate the effect of obesity on the stages of fibrosis discordance between FibroScan and liver biopsy. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of liver disease worldwide. Accurate fibrosis assessment is essential in MASLD patients for prognosis a...